News
The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...
10hon MSN
A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...
Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.
18h
Study Finds on MSNAre You On The Road To Alzheimer’s? Scientists Find 4 Distinct Routes That Lead To DiseaseResearchers reveal four distinct sequences of health conditions that commonly lead to Alzheimer’s, offering new hope for ...
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...
Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.
6d
News-Medical.Net on MSNClinical trial examines whether Ambroxol can slow dementia in people with Parkinson'sResearchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...
A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results